Why were broad-spectrum penicillins developed?

Broad-spectrum penicillins were developed to extend the clinical utility of penicillin-based treatments to include infections caused by gram-negative rods.1

While naturally occurring penicillins are highly effective against many bacteria, they have a limited spectrum of activity, primarily targeting gram-positive organisms. By chemically modifying the basic penicillin molecule (6-aminopenicillanic acid), scientists created semisynthetic broad-spectrum agents—such as ampicillin and amoxicillin—that are capable of combating gram-negative bacteria. These medications are particularly useful for treating conditions like urinary tract infections, as well as typhoid and enteric fevers.21